Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hirsch

Showing results (291-300 of 350) with videos related to

Pageof 35
Sort By:
JAMA|March 22, 2007
One-year cardiovascular event rates in outpatients with atherothrombosisPh Gabriel Steg, Deepak L Bhatt, Peter W F Wilson, et al.
The American Journal of Medicine|May 31, 2001
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudicationW R Hiatt, J G Regensteiner, M A Creager, et al.
European Heart Journal|September 2, 2009
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health RegistryMark J Alberts, Deepak L Bhatt, Jean-Louis Mas, et al.
The American Journal of Cardiology|February 16, 2010
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)Christopher P Cannon, Karen E Rhee, Robert M Califf, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 3, 2013
Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudicationTimothy P Murphy, Matthew R Reynolds, David J Cohen, et al.
Atherosclerosis|May 13, 2018
Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) studyNing Ding, Lucia Kwak, Shoshana H Ballew, et al.
Journal of General Internal Medicine|December 11, 2002
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician surveyMary McGrae McDermott, Elizabeth A Hahn, Philip Greenland, et al.
Circulation|October 5, 2011
Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD)Kevin M Harris, Craig E Strauss, Kim A Eagle, et al.
JAMA|September 19, 2001
Peripheral arterial disease detection, awareness, and treatment in primary careA T Hirsch, M H Criqui, D Treat-Jacobson, et al.
European Heart Journal|March 27, 2018
High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) StudyKunihiro Matsushita, Lucia Kwak, Chao Yang, et al.
Pageof 35

Showing results (291-300 of 350) with videos related to

Sort By:
Pageof 35
JAMA|March 22, 2007
One-year cardiovascular event rates in outpatients with atherothrombosisPh Gabriel Steg, Deepak L Bhatt, Peter W F Wilson, et al.
The American Journal of Medicine|May 31, 2001
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudicationW R Hiatt, J G Regensteiner, M A Creager, et al.
European Heart Journal|September 2, 2009
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health RegistryMark J Alberts, Deepak L Bhatt, Jean-Louis Mas, et al.
The American Journal of Cardiology|February 16, 2010
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)Christopher P Cannon, Karen E Rhee, Robert M Califf, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 3, 2013
Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudicationTimothy P Murphy, Matthew R Reynolds, David J Cohen, et al.
Atherosclerosis|May 13, 2018
Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) studyNing Ding, Lucia Kwak, Shoshana H Ballew, et al.
Journal of General Internal Medicine|December 11, 2002
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician surveyMary McGrae McDermott, Elizabeth A Hahn, Philip Greenland, et al.
Circulation|October 5, 2011
Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD)Kevin M Harris, Craig E Strauss, Kim A Eagle, et al.
JAMA|September 19, 2001
Peripheral arterial disease detection, awareness, and treatment in primary careA T Hirsch, M H Criqui, D Treat-Jacobson, et al.
European Heart Journal|March 27, 2018
High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) StudyKunihiro Matsushita, Lucia Kwak, Chao Yang, et al.
Pageof 35